José Luis Vizmanos
Ph. D.
Department of Genetics
School of Sciences
Research Building. University of Navarra
Spain
Name/email consistency: high
- CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2. Aranaz, P., Hurtado, C., Erquiaga, I., Miguéliz, I., Ormazábal, C., Cristobal, I., García-Delgado, M., Novo, F.J., Vizmanos, J.L. Haematologica (2012)
- NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder. Vizmanos, J.L., Novo, F.J., Román, J.P., Baxter, E.J., Lahortiga, I., Larráyoz, M.J., Odero, M.D., Giraldo, P., Calasanz, M.J., Cross, N.C. Cancer Res. (2004)
- Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases. Vizmanos, J.L., Hernández, R., Vidal, M.J., Larráyoz, M.J., Odero, M.D., Marín, J., Ardanaz, M.T., Calasanz, M.J., Cross, N.C. Hematol. J. (2004)
- Two new molecular PML-RARalpha variants: implications for the molecular diagnosis of APL. Vizmanos, J.L., Larrráyoz, M.J., Odero, M.D., Lasa, R., González, M., Novo, F.J., Calasanz, M.J. Haematologica (2002)
